Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.

Find out how to create competitive advantage by developing a fit-for-purpose supply chain that supports the market’s paradigm shift.

World Courier uses our expertise and experience to deal with custom requirements before the commercial supply chain has to think about them. Hear from Sam Herbert, President of World Courier as he discusses the lessons we have learnt.

An overview of the risks inherent to global pharmaceutical logistics and the associated risk management. Get your white paper now.

Today’s Russian clinical trial market is worth 880 million dollars and there is every expectation that it will continue to grow. The only question is, at what rate?

Japan is the world's second largest single-country pharmaceutical market, accounting for approximately 10 per cent of global drug sales, and is expanding very quickly.

What are some of the challenges of shipping into Latin America?

Find out in this short video.

This article first appeared on the Journal for Clinical Studies, Oct 2015

What role does Australia play in the growth of global healthcare, and how is the market continuing to change?

Global logistics will always be challenging..and sometimes, even out of this world...

Scandinavia and Nordic progression with clinical trials

Thailand is becoming more like other, more developed markets in the region, and as part of the ASEAN region, it offers excellent opportunities. Growth is expected in both clinical and commercial prospects.

Although the world of specialty logistics may be growing smaller, it does not mean it is getting any less complex...

Learn how to protect your supply chain against counterfeit drugs with our white paper